Is early-onset cancer an emerging global epidemic? Current evidence and future implications

T Ugai, N Sasamoto, HY Lee, M Ando… - Nature Reviews …, 2022 - nature.com
Over the past several decades, the incidence of early-onset cancers, often defined as
cancers diagnosed in adults< 50 years of age, in the breast, colorectum, endometrium …

The current status of risk-stratified breast screening

AK Clift, D Dodwell, S Lord, S Petrou, SM Brady… - British journal of …, 2022 - nature.com
Apart from high-risk scenarios such as the presence of highly penetrant genetic mutations,
breast screening typically comprises mammography or tomosynthesis strategies defined by …

[HTML][HTML] Prediction of breast cancer using machine learning approaches

R Rabiei, SM Ayyoubzadeh, S Sohrabei… - Journal of biomedical …, 2022 - ncbi.nlm.nih.gov
Background: Breast cancer is considered one of the most common cancers in women
caused by various clinical, lifestyle, social, and economic factors. Machine learning has the …

Genome-wide risk prediction of common diseases across ancestries in one million people

N Mars, S Kerminen, YCA Feng, M Kanai, K Läll… - Cell Genomics, 2022 - cell.com
Polygenic risk scores (PRS) measure genetic disease susceptibility by combining risk effects
across the genome. For coronary artery disease (CAD), type 2 diabetes (T2D), and breast …

[HTML][HTML] Lung cancer is also a hereditary disease

PR Benusiglio, V Fallet, M Sanchis-Borja… - European …, 2021 - Eur Respiratory Soc
Pathogenic genetic variants (formerly called mutations) present in the germline of some
individuals are associated with a clinically relevant increased risk of developing lung cancer …

Clinical utility of polygenic risk scores: a critical 2023 appraisal

S Koch, J Schmidtke, M Krawczak… - Journal of Community …, 2023 - Springer
Since their first appearance in the context of schizophrenia and bipolar disorder in 2009,
polygenic risk scores (PRSs) have been described for a large number of common complex …

Polygenic risk scores: An overview from bench to bedside for personalised medicine

B Cross, R Turner, M Pirmohamed - Frontiers in Genetics, 2022 - frontiersin.org
Since the first polygenic risk score (PRS) in 2007, research in this area has progressed
significantly. The increasing number of SNPs that have been identified by large scale GWAS …

Will polygenic risk scores for cancer ever be clinically useful?

A Sud, C Turnbull, R Houlston - Npj Precision Oncology, 2021 - nature.com
Genome-wide association studies (GWAS) have identified associations between common
genetic variants, single nucleotide polymorphisms (SNPs) and the risk of developing …

Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans

H Shams, X Shao, A Santaniello, G Kirkish, A Harroud… - Brain, 2023 - academic.oup.com
Polygenic inheritance plays a pivotal role in driving multiple sclerosis susceptibility, an
inflammatory demyelinating disease of the CNS. We developed polygenic risk scores (PRS) …

Generalizability of polygenic risk scores for breast cancer among women with European, African, and Latinx ancestry

C Liu, N Zeinomar, WK Chung, K Kiryluk… - JAMA network …, 2021 - jamanetwork.com
Importance Multiple polygenic risk scores (PRSs) for breast cancer have been developed
from large research consortia; however, their generalizability to diverse clinical settings is …